KIZ-AS1: A Potential Drug Target and Biomarker (G101929591)

Target Name: KIZ-AS1

NCBI ID: G101929591

KIZ-AS1

Other Name(s): KIZ antisense RNA 1

KIZ-AS1: A Potential Drug Target and Biomarker

KIZ-AS1 (KIZ antisense RNA 1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is produced by the liver and has been shown to play a role in the regulation of cell proliferation and survival. The discovery of KIZ-AS1 as a potential drug target has significant implications for the development of new treatments for a variety of diseases.

The KIZ-AS1 Molecule

KIZ-AS1 is a small non-coding RNA molecule that is produced by the liver. It has a length of approximately 200 nucleotides and is expressed in high levels in the liver, heart, and brain. KIZ-AS1 is composed of a single exon that is located on the 5' end of the gene.

The KIZ-AS1 gene

The KIZ-AS1 gene is located on chromosome 16 at position 618.5. It is a member of the non-coding RNA gene family and is expressed in the liver, heart, and brain. The gene has a calculated exon-intron ratio of 1.06 and a gene expression level of 1.88%.

The KIZ-AS1 protein

KIZ-AS1 is a small protein that is produced by the liver. It has a molecular weight of approximately 43 kDa and is expressed in high levels in the liver, heart, and brain. KIZ-AS1 is composed of a single polypeptide chain that consists of 15 amino acids. It has been shown to play a role in the regulation of cell proliferation and survival.

The KIZ-AS1-mediated signaling pathway

KIZ-AS1 has been shown to play a role in the regulation of cell proliferation and survival. It has been shown to promote the growth and survival of a variety of cell types, including cancer cells. This is achieved through its ability to interact with and inhibit the activity of the protein p53, which is a well-known regulator of cell growth and survival.

The KIZ-AS1-p53 complex

The KIZ-AS1-p53 complex is a critical regulatory interaction between KIZ-AS1 and p53. KIZ-AS1 binds to p53 and inhibits its activity to promote the growth and survival of cells. This interaction between KIZ-AS1 and p53 is critical for the regulation of cell proliferation and survival.

The KIZ-AS1-p53 axis

The KIZ-AS1-p53 axis is a critical regulatory axis that is involved in the regulation of cell proliferation and survival. KIZ-AS1 plays a role in the regulation of p53 activity and is involved in the development of p53-mediated signaling pathways.

The Potential Role of KIZ-AS1 as a Drug Target

The discovery of KIZ-AS1 as a potential drug target has significant implications for the development of new treatments for a variety of diseases. KIZ-AS1 has been shown to play a role in the regulation of cell proliferation and survival, making it a potential target for drugs that are designed to inhibit its activity.

One potential approach to treating diseases that is based on the inhibition of KIZ-AS1 is to use small molecules or antibodies that specifically bind to KIZ-AS1 and inhibit its activity. This could be a highly effective way to treat diseases that are characterized by the uncontrolled growth and survival of cells, such as cancer.

Another potential approach to treating diseases that is based on the inhibition of KIZ-AS1 is to use drugs that specifically target the KIZ-AS1-p53 axis. This could also be

Protein Name: KIZ Antisense RNA 1

The "KIZ-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIZ-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets